Stock Events

Stock Events

LTR Pharma 

A$0.4250
8
-A$0.01-1.16% 04:57 Today

Statistics

Day High
0.44
Day Low
0.405
52W High
0.75
52W Low
0.35
Volume
170,081
Avg. Volume
145,740
Mkt Cap
77.26M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-7,697.83%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
184,000Revenue
-14.16MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow LTP.AU. It's not an investment recommendation.
Botanix Pharmaceuticals Limited
2
BOT.AU

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
CSL
CSL.AU
Mkt Cap58.85B
CSL Limited is a global biotechnology leader that develops and delivers innovative biotherapies and influenza vaccines, directly competing in the pharmaceutical and healthcare sectors.
Resmed
RMD.AU
Mkt Cap43.56B
ResMed is a company that designs, manufactures, and markets medical devices globally, competing with LTR Pharma in the healthcare equipment sector.
Cochlear
COH.AU
Mkt Cap7.95B
Cochlear Limited offers implantable hearing solutions, competing in the medical devices segment of the healthcare market.
Fisher & Paykel Healthcare Limited
FPH.NZ
Mkt Cap0
Fisher & Paykel Healthcare manufactures medical devices and systems, directly competing with LTR Pharma in the healthcare technology field.
Sonic Healthcare
SHL.AU
Mkt Cap10.5B
Sonic Healthcare provides laboratory and radiology services worldwide, competing in the healthcare services sector.
Pro Medicus
PME.AU
Mkt Cap20.59B
Pro Medicus Limited offers medical imaging software and services, competing in the healthcare technology and software sector.
Nanosonics Limited
NAN.AU
Mkt Cap965.48M
Nanosonics Ltd. specializes in infection control solutions, competing in the medical devices and healthcare safety products market.
Ansell
ANN.AU
Mkt Cap4.4B
Ansell Limited specializes in protective industrial and medical gloves, competing in the healthcare protective wear market.

About

LTR Pharma Limited, a clinical-stage pharmaceutical company, engages in the research and development of intranasal spray for the treatment erectile dysfunction (ED) in Australia. Its lead product candidate is SPONTAN, an intranasal delivery technology, an oral PDE5 inhibitor and vardenafil HCL for the treatment of ED. The company was incorporated in 2020 and is headquartered in Brisbane, Australia.
Show More
CEO
Mr. Lee Rodne
Country
Australia
ISIN
AU0000305294

Listings

OTC Link
US
LTPLF
AU
AU
LTP.AU

0 Comments

Share your thoughts

FAQs

What is LTR Pharma stock price today?▼
The current price of LTP.AU is A$0.43 AUD — it has decreased by -1.16% in the past 24 hours. Watch LTR Pharma stock price performance more closely on the chart.
What is LTR Pharma stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Australia Exchange exchange LTR Pharma stocks are traded under the ticker LTP.AU.
Is LTR Pharma stock price growing?▼
LTP.AU stock has fallen by -3.41% compared to the previous week, the month change is a -9.57% fall, over the last year LTR Pharma has showed a -15% decrease.
What is LTR Pharma market cap?▼
Today LTR Pharma has the market capitalization of 77.26M
What is LTR Pharma revenue for the last year?▼
LTR Pharma revenue for the last year amounts to 184,000 AUD.
What is LTR Pharma net income for the last year?▼
LTP.AU net income for the last year is -14.16M AUD.
In which sector is LTR Pharma located?▼
LTR Pharma operates in the Health & Wellness sector.
When did LTR Pharma complete a stock split?▼
LTR Pharma has not had any recent stock splits.
Where is LTR Pharma headquartered?▼
LTR Pharma is headquartered in Brisbane, Australia.